Third Party License Agreement means any agreement entered into by a Party or its Affiliate with a Third Party, or any amendment or supplement thereto, in each case following the Effective Date, whereby royalties, fees or other payments are to be made by a Party or its Affiliate to such Third Party in connection with the grant of rights under intellectual property rights Controlled by such Third Party, which rights are necessary or useful for the Development, manufacture, use or Commercialization of the Collaboration Compound or Product.
Third Party License Agreement means any agreement entered into after the Effective Date with a Third Party, or any amendment or supplement thereto, whereby royalties, fees or other payments are to be made to such Third Party in connection with the grant of rights under Patent Rights Controlled by a Third Party in a country, which Patent Rights are necessary to Develop, manufacture, have made, import, export, use or Commercialize the Product. For clarity, if an option under an already existing agreement with a Third Party is exercised and with such option, additional payments are due for using the “opt-in intellectual property”, such option exercise shall be deemed an “agreement entered into after the Effective Date with a Third Party” as foreseen in this definition and payments for the “opt-in intellectual property” shall be considered deductible in accordance with the terms of this Agreement.
Third Party License Agreement has the meaning set forth in Section 9.16.
Examples of Third Party License Agreement in a sentence
Licensor shall promptly notify Company of any default under, termination or amendment of, Third Party License Agreement.
For the purposes of clarity, Ablynx (and not Merck) shall be responsible for all of the financial and other obligations of Ablynx (and/or any of its Affiliates) under each Ablynx Third Party License Agreement, including any and all financial obligations thereunder with respect to Net Sales of Merck and its Related Parties.
Ablynx further covenants and agrees that during the Term of this Agreement, (a) it will satisfy all of its obligations under (including making all payments), and take all steps necessary to maintain in full force and effect, each Ablynx Third Party License Agreement; (b) it will not assign (except CONFIDENTIAL TREATMENT REQUESTED.
These procedures are for the benefit of the City and are not intended to establish an administrative requirement that must be exhausted by the protesting respondent prior to pursuing any legal remedy which may be available.
The sublicense provided in this subsection 5(b) is subject to the termination provisions of the Existing Third Party License Agreement.
More Definitions of Third Party License Agreement
Third Party License Agreement means any agreement between Connect LLC and a third party under which Connect LLC grants a license or otherwise provides access or use rights to any of the Licensed Data to the third party or the third party’s customers or end users. “Option Holder” means Change Solutions (or any Subsidiary of any Echo Party that it designates). Capitalized terms used in this Section 2.5 without definition shall have the meanings given to them under the Option Agreement.
Third Party License Agreement means any agreement entered into by a Party or its Affiliate with a Third Party, or any amendment or supplement thereto, in each case following the Effective Date, whereby royalties, fees or other payments are to be made by a Party or its Affiliate to such Third Party in connection with the grant of rights under intellectual property rights Controlled by such Third Party, which rights are necessary or useful to research, Develop, manufacture, have made, import, export, use or Commercialize a Licensed Compound or Licensed Product.
Third Party License Agreement means any agreement (including any settlement agreement) entered into after the Effective Date with a Third Party, whereby royalties are to be paid to such Third Party based on the grant of rights under valid Patent Rights Controlled by such Third Party in a country or countries, which Patent Rights are Necessary to Commercialize the Licensed Product free from infringement of such Patent Rights. For purposes of this definition, “Necessary to Commercialize” means, with respect to a particular Licensed Product and Third Party Patent Rights in a particular country or countries, [***]. For clarity, an agreement under which rights are obtained with respect to any Independently Active Therapeutic Ingredient is not a Third Party License Agreement.
Third Party License Agreement means any agreement entered into by Akouos, any of its Affiliates or any Sublicensee with a Third Party, as applicable depending upon whether Akouos, its Affiliate or Sublicensee is the entity that will be paying royalties on Net Sales of the relevant Licensed Product(s), or any amendment or supplement thereto, in each case after the Effective Date, whereby royalties, fees or other payments are to be made by Akouos, its Affiliates or any Sublicensee (as applicable) to such Third Party in connection with the grant of license rights under Intellectual Property that covers or claims either the composition of matter, manufacture or the method of use of any vector or Licensed Gene Target or Licensed Gene Target regulatory element for the relevant Licensed Product in the Field of Use that is Controlled by such Third Party, which rights Akouos or its Affiliates or Sublicensee, as applicable, reasonably determine are necessary to manufacture, have made, import, export, use, sell, offer for sale or otherwise commercialize the Licensed Product in the Field of Use.
Third Party License Agreement shall have the meaning set forth in Section 3.3.4(d).
Third Party License Agreement is defined in Article 6.7(b).
Third Party License Agreement means any agreement entered into after the Effective Date with a Third Party, whereby royalties or milestone payments are to be paid to such Third Party based on the grant of rights under valid Patent Rights controlled by such Third Party in a country or countries, provided that such Patent Rights (a) are determined by RayzeBio to be reasonably necessary to Develop, Manufacture or Commercialize any Licensed Product free from infringement of such Patent Rights (“Necessary for Commercialization”) and (b) exclude any Patent Rights to the extent related to (i) radioactive isotopes or radionuclides, (ii) chelators for a radioactive isotope or radionuclide, (iii) any chemical linkers to such chelators or (iv) other drug delivery components for the delivery of radioactive isotopes or radionuclides.